Gene · 29968
Papers1,996
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,996
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Morphological and Molecular Bases of Male Infertility: A Closer Look at Sperm Flagellum. | Genes (Basel) | 2023 | 36833310 | PubTator, text mining | PubMed |
| Prognostic Significance of Amino Acid Metabolism-Related Genes in Prostate Cancer Retrieved by Machine Learning. | Cancers (Basel) | 2023 | 36831650 | PubTator, text mining | PubMed |
| A Novel Molecular Analysis Approach in Colorectal Cancer Suggests New Treatment Opportunities. | Cancers (Basel) | 2023 | 36831448 | PubTator, text mining | PubMed |
| A stay of execution: ATF4 regulation and potential outcomes for the integrated stress response. | Front Mol Neurosci | 2023 | 36825279 | PubTator, text mining | PubMed |
| PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma. | Nat Commun | 2023 | 36823188 | PubTator, text mining | PubMed |
| Hexafluoro-2-propanol represses colorectal cancer proliferation by regulating transaminases. | Acta Biochim Pol | 2023 | 36821417 | PubTator, text mining | PubMed |
| Targeting PSAT1 to mitigate metastasis in tumors with p53-72Pro variant. | Signal Transduct Target Ther | 2023 | 36788227 | PubTator, text mining | PubMed |
| Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy. | Int J Biol Sci | 2023 | 36778122 | PubTator, text mining | PubMed |
| Organophilized Montmorillonites as Fillers for Silicone Pressure-Sensitive Adhesives. | Materials (Basel) | 2023 | 36769956 | PubTator, text mining | PubMed |
| Proteins Adsorbed during Intraoperative Hemoadsorption and Their In Vitro Effects on Endothelium. | Healthcare (Basel) | 2023 | 36766885 | PubTator, text mining | PubMed |
| Macrophage differentiation is marked by increased abundance of the mRNA 3' end processing machinery, altered poly(A) site usage, and sensitivity to the level of CstF64. | Front Immunol | 2023 | 36761770 | PubTator, text mining | PubMed |
| The protective effects of phosphoserine aminotransferase 1 (PSAT1) against hepatic ischemia-reperfusion injury. | J Cell Commun Signal | 2023 | 36745318 | PubTator, text mining | PubMed |
| PSAT1 positively regulates the osteogenic lineage differentiation of periodontal ligament stem cells through the ATF4/PSAT1/Akt/GSK3β/β-catenin axis. | J Transl Med | 2023 | 36732787 | PubTator, text mining | PubMed |
| Measuring the multifaceted roles of mucin-domain glycoproteins in cancer. | Adv Cancer Res | 2023 | 36725114 | PubTator, text mining | PubMed |
| NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma. | Cancer Biol Ther | 2023 | 36722045 | PubTator, text mining | PubMed |
| Multi-omics Analysis of the Role of PHGDH in Colon Cancer. | Technol Cancer Res Treat | 2023 | 36707056 | PubTator, text mining | PubMed |
| Mono(2-ethylhexyl) phthalate induces transcriptomic changes in placental cells based on concentration, fetal sex, and trophoblast cell type. | Arch Toxicol | 2023 | 36695872 | PubTator, text mining | PubMed |
| Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer. | J Pers Med | 2023 | 36675817 | PubTator, text mining | PubMed |
| Role of Impaired Glycolysis in Perturbations of Amino Acid Metabolism in Diabetes Mellitus. | Int J Mol Sci | 2023 | 36675238 | PubTator, text mining | PubMed |
| A Transcriptomic Regulatory Network among miRNAs, lncRNAs, circRNAs, and mRNAs Associated with L-leucine-induced Proliferation of Equine Satellite Cells. | Animals (Basel) | 2023 | 36670748 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/29968/papers?page=18